4.10.26.1Vertical
Adult Neurological Speech Rehabilitation
SLP programs treating aphasia, dysphagia, and communication disorders in stroke and TBI patients.
Market snapshot
These figures describe Speech-Language Pathology (4.10.26), the segment that Adult Neurological Speech Rehabilitation sits within — not Adult Neurological Speech Rehabilitation on its own.
FragmentationConsolidatingEstimate
Within therapy offices (NAICS 621340) and pediatric services; the Census Bureau does not separate speech-language pathology, so the segment is not separately sized.
Business model & economics
Revenue model
Per-visit and per-session therapy reimbursement
Key economics
- Recurring revenue
- High
- EBITDA margin
- 12–22%
- Capex intensity
- Low
recurring multi-visit therapy
Characteristics
- Pediatric speech therapy an active roll-up area.
- Rising identification of pediatric needs.
- SLP shortage constrains supply.
M&A deal context
Deal activityModerate
Who’s acquiring
- Pediatric multi-therapy platforms
- PE-backed therapy consolidators
- Rehabilitation acquirers
What’s driving deals
- Pediatric multi-therapy roll-up.
- Rising pediatric-needs identification.
- SLP workforce constraints.
Find Adult Neurological Speech Rehabilitation acquisition targets
Search Acquisera’s index for companies classified under Adult Neurological Speech Rehabilitation (4.10.26.1) and build a targeted deal pipeline.
Search companies